Vitrum Osteomag

Vitrum Osteomag: a complex drug for the prevention and treatment of osteoporosis

Vitrum Osteomag is a complex drug produced by Unipharm Inc. in the United States of America. It contains several important macro and micronutrients such as calcium, magnesium, vitamin D3, zinc, copper, manganese and boron, which are essential for healthy bones and teeth. The drug is presented in the form of film-coated tablets.

The drug Vitrum Osteomag is recommended for the prevention and complex treatment of osteopenia and osteoporosis, especially in old age and in women during menopause and the postmenopausal period. It can also be used for hypocalcemia, inadequate or unbalanced nutrition in minerals (calcium, magnesium).

The drug has several contraindications, including hypersensitivity, urolithiasis, severe renal dysfunction, hypercalcemia and hypercalciuria. Taking the drug may cause intestinal dysfunction such as constipation and gas. In addition, Vitrum Osteomag affects the absorption of tetracycline antibiotics, salicylates (including acetylsalicylic acid), beta-blockers and indirect anticoagulants, so it must be taken 2 hours before or after taking other medications.

There is no data on a possible overdose of Vitrum Osteomag. However, the recommended dose should not be exceeded. When taking large doses, monitoring of renal function is necessary. The drug is not recommended for children under 12 years of age. Taking 2 Vitrum Osteomag tablets per day replenishes the daily need for vitamin D, calcium and magnesium. For women starting from the premenopausal period, continuous use of the drug is recommended.

In general, the drug Vitrum Osteomag is an important comprehensive remedy for the prevention and treatment of osteoporosis. Its use can help strengthen bones and teeth and reduce the risk of osteoporosis. However, before starting to take the drug, you should consult your doctor.